BIOCRYST PHARMACEUTICALS INC — DEF 14A

BIOCRYST PHARMACEUTICALS INC of DURHAM, NC filed a DEF 14A with the SEC on 2025-04-24. Industry: Biological Products, (No Diagnostic Substances).

Filing

Documents (12)

SeqTypeDescription
1DEF 14ADEF 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
6GRAPHICbcrx-20250424_g1.jpg
7GRAPHICbcrx-20250424_g2.jpg
8GRAPHICbcrx-20250424_g3.jpg
9GRAPHICbcrx-20250424_g4.jpg
10GRAPHICbcrx-20250424_g5.jpg
11GRAPHICbcrx-20250424_g6.jpg
24XMLEXTRACTED XBRL INSTANCE DOCUMENT

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-23DEF 14A
2026-04-23DEFA14A
2025-04-24DEF 14A
2025-04-24DEFA14A
2024-04-25DEF 14A
2024-04-25DEFA14A
2023-04-27DEFA14A
2023-04-27DEF 14A
2022-05-26DEFA14A
2022-04-25DEFA14A
2022-04-25DEF 14A
2021-04-13DEFA14A

More